What Researchers Did
Researchers described the use of indocyanine green fluorescent angiography (ICFA) to guide hyperbaric oxygen therapy (HBO₂) in a 67-year-old female patient with breast soft tissue radiation necrosis.
What They Found
A 67-year-old female with breast soft tissue radiation necrosis received 20 hyperbaric oxygen (HBO₂) treatments before surgery. Intraoperative indocyanine green fluorescent angiography (ICFA) identified a hypovascular area, prompting additional HBO₂ treatments. After eight postoperative HBO₂ sessions, ICFA demonstrated improved vascularity in the previously identified region.
What This Means for Canadian Patients
This case suggests that indocyanine green fluorescent angiography (ICFA) could help tailor hyperbaric oxygen therapy (HBO₂) for Canadian patients with soft tissue radiation necrosis. By guiding treatment, ICFA may optimize wound healing and improve outcomes for those affected by radiation damage.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a case report, the findings are limited to a single patient and may not be generalizable to a broader population.